BMY
BRISTOL MYERS SQUIBB CO
NYSE · Healthcare · Drug Manufacturers - General · US
$60.64
+0.12%Forward multiples
Based on analyst estimates
- P/E forward
- 9.41x
- P/E 2026E
- 9.57x
- P/E 2027E
- 9.17x
- P/E 2028E
- 11.47x
- P/S forward
- 2.56x
Trailing multiples
Trailing twelve months
- P/E TTM
- 13.36x
- PEG TTM
- 0.32x
- Price / book
- 5.55x
- Price / sales
- 2.52x
- Price / cash flow
- 9.69x
Enterprise value
- Enterprise value
- $155.9B
- EV / sales
- 3.17x
- EV / EBITDA
- 9.27x
- EV / EBIT
- 11.26x
- Market cap
- $123.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026